Biomarin Pharmaceutical Inc

Ownership Transactions Reported by 24 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	7	-258K	100%	$85.00	-$21.9M
Net	-7	-258K	-100%		-$21.9M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jean Jacques Bienaime	Director	$55.6M	-$11.8M	-17.5%	May 20, 2024
Henry J. Fuchs	President, Worldwide R&D	$15.7M	-$3.01M	-16.1%	Sep 13, 2024
Richard A. Meier	Director	$9.23M			Jun 3, 2024
Alexander Hardy	Chief Executive Officer, Director	$8.86M			Nov 29, 2024
Elaine J. Heron	Director	$7.47M			Jun 3, 2024
Brian Mueller	EVP, Chief Financial Officer	$5.89M	-$376K	-6%	Jun 28, 2024
Jeffrey Robert Ajer	EVP, Chief Commercial Officer	$5.54M	-$763K	-12.1%	May 2, 2024
Charles Greg Guyer	EVP, Chief Technical Officer	$4.57M	-$350K	-7.11%	Nov 12, 2024
George Eric Davis	EVP, Chief Legal Officer	$4.23M	-$5.37M	-56%	May 28, 2024
D. E. I. Pyott	Director	$3.83M			May 21, 2024
V. Bryan Lawlis	Director	$3.19M			May 23, 2023
Robert J. Hombach	Director	$2.71M			May 21, 2024
Dennis Slamon	Director	$2.62M			Mar 18, 2024
Willard H. Dere	Director	$2.49M			May 21, 2024
Gregory R. Friberg	EVP, Chief R&D Officer	$2.47M			Sep 30, 2024
Elizabeth M. Anderson	Director	$2.14M			May 21, 2024
Andrea Acosta	GVP, Chief Accounting Officer	$1.75M			Apr 30, 2021
Maykin Ho	Director	$1.65M			May 21, 2024
Cristin Hubbard	EVP, Chief Commercial Officer	$1.49M			May 20, 2024
Mark J. Alles	Director	$1.45M			May 23, 2023
Erin Burkhart	GVP, Chief Accounting Officer	$1.3M	-$270K	-17.2%	Aug 13, 2024
Athena Countouriotis	Director	$532K			May 21, 2024
Mark J. Enyedy	Director	$532K			May 21, 2024
Barbara W. Bodem	Director	$532K			May 21, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.